DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Thromboembolic Complications Related to Asparaginase in Children With Acute Lymphoblastic Leukemia (ALL) Treated According to NOPHO ALL 2008

Information source: Oslo University Hospital
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Thromboembolism; Acute Lymphoblastic Leukemia

Phase: N/A

Status: Recruiting

Sponsored by: Oslo University Hospital

Official(s) and/or principal investigator(s):
Ellen Ruud, MD PhD, Principal Investigator, Affiliation: Oslo University Hospital

Overall contact:
Ellen Ruud, MD PhD, Phone: +47 23074560, Email: ellen.ruud@rikshospitalet.no

Summary

The study will examine the prevalence of venous thromboembolism in children with acute lymphoblastic leukaemia treated in accordance with NOPHO ALL-2008. The investigators will prospectively study clinical symptomatic thromboses, asymptomatic central line-associated thromboses, and infections.

Clinical Details

Official title: Thromboembolic Complications Related to Asparaginase in Children With ALL Treated According to NOPHO ALL 2008

Study design: Observational Model: Cohort, Time Perspective: Prospective

Primary outcome:

Clinical evident thrombosis

Asymptomatic central line-associated thrombosis

Secondary outcome: Positive blood culture

Eligibility

Minimum age: 1 Year. Maximum age: 16 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Acute lymphoblastic leukaemia,

- Age 1 year to 16 years old,

- Central line,

- Protocol NOPHO ALL 2008.

Exclusion Criteria:

- Refusal of participation,

- Treated according to protocol other than NOPHO ALL 2008.

Locations and Contacts

Ellen Ruud, MD PhD, Phone: +47 23074560, Email: ellen.ruud@rikshospitalet.no

Rikshospitalet, Dep of Pediatrics, Oslo 0027, Norway; Recruiting
Ellen Ruud, MD PhD, Principal Investigator
Additional Information

The home page for NOPHO who is responsible for the ALL treatment protocol

Starting date: September 2009
Last updated: September 11, 2012

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017